“…However, the literature contains differing opinions regarding the magnitude of optimal advancement [2,14,37,40,50] and predictability and reliability of clinical results [5,8,21,29,40,43,50]. Some of the studies are limited by cohort size [3,5,19], cohort heterogeneity [5,9,10,15,17,19,55], short followup [3,10,20,29,55], or inadequate scoring systems [10,17,20,26,50]. Nonetheless, the consensus suggests that with proper indications and accurate technique, TTA still plays a role Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.…”